543 results
The power of BIG DATA for PCI in practice
Watch this session if you want to understand the value of BIG DATA from global registries in interventional cardiology, to explore regional differences in percutaneous coronary interventions and potential impact on clinical outcomes and to learn how large registry data can impact your practice.
Speakers: Marco Roffi,...
Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?
25 Jun 2020 – From PCR e-Course 2020
Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.
Videos included on this page: the abstract presentation and an Investigator Perspective.
PCR e-Course 2020 Clinical cases
25 Jun 2020 – From PCR e-Course 2020
Watch a series of best clinical cases presented at the PCR e-Course 2020:
- ACS-patient with culprit in a coronary ectasia
- Coronary stenting in an ectatic artery
- Challenging PCI after aortic valve-in-valve implantation
- Cisplatin-induced coronary artery thrombosis presented as ACS
- MOCA I study: microvascular obstruction measured using dMVR
- The many faces of in-stent...
Abstracts on stent & scaffolds - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of abstracts from PCR e-Course 2020 on the topic of Stents & scaffolds:
- 12-month follow-up results of the first cohort of the BIOSOLVE-IV registry
- The effects of shockwave lithotripsy on DES
- 5-year data of the drug-eluting absorbable metal scaffold in BIOSOLVE-II
- Bailout stenting post drug coated balloons;...
Target all comers 3-year results - Evaluation of Cobalt Chrome Rapamycin Drug Eluting Stent
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to review the Firehawk family TES technology and early clinical outcomes in the treatment of atherosclerotic lesions, to gain the first sight of the 3-year results of the TARGET AC trial and to look into the Future Directions of Target...
Hotlines and innovations on left main & multivessel disease - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of left main & multivessel disease:
- One-year clinical outcomes of complex PCI treated with use of Ultimaster stent
- Impact of residual SYNTAX score on all-cause death at 10 yrs in the SYNTAX trial
Hotlines and innovations on stents & scaffolds - PCR e-Course 2020
25 Jun 2020 – From PCR e-Course 2020
View a selection of hot lines from PCR e-Course 2020 on the topic of stents & scaffolds:
- Advances in coronary stenting - Outcome of thinnest strut DES
- TARGET All Comers Trial- three-year Results
- Final results of the REMEDEE registry
- e-ULTIMASTER registry: final results and differences across continents
- Main results of the Biofreedom...
Update on the regulation of high-risk medical devices: a transatlantic perspective
25 Jun 2020 – From PCR e-Course 2020
Watch this session if you want to get an update on new developments in the regulation of high-risk medical devices in Europe and the USA and to learn about opportunities for physicians to become more involved in the regulatory environment.
This session was originally presented during PCR...
Last frontiers in treatment of high bleeding risk patients
Watch this session if you want to learn from experts the complexity of HBR patients, to discover newest data on DAPT in this population and to get a first-hand update on upcoming major development in DAPT for HBR patients.
Speaker: Davide Capodanno
This interview supported by Terumo was...
The new paradigm for coronary interventions
Watch this session to understand indications for DEB vs. DES & the potential advantage of a sustained sirolimus release when utilised in a DEB, and to get insights into the breakthrough technology of SELUTION SLR & its initial clinical data & clinical experience.
Speakers: Stephan Windecker, Robert...
